MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fphar.2023.1167959

Медицинская библиотека · Frontiers in pharmacology · 2023

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer.

Hu Haoyue, Tan Songtao, Xie Meng, Guo Peng, Yu Qiang, Xiao Juan, Zhao Kangrui, Liao Qiong, Wang Yi

Клинический случайСтатьяПеревод в очереди

Аннотация

In non-small cell lung cancer (NSCLC), two key genetic alterations, epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements, are commonly believed to be mutually exclusive. Studies have reported that concurrent EGFR/ALK co-mutation in non-small cell lung cancer patients is rare, with a prevalence ranging from 0.1% to 1.6%. However, the clinical and pathological characteristics of these patients are not well-defined, and the optimal treatment approach for such cases remains controversial. In this report, we present a case of stage IV lung adenocarcinoma with both epidermal growth factor receptor and anaplastic lymphoma kinase mutations, along with high PD-L1 expression. The patient initially received treatment with epidermal growth factor receptor tyrosine kinase inhibitors (TKIs), but the disease progressed. However, following a switch to ALK-TKI therapy and local radiotherapy, the lesion showed regression. Our report also provides a comprehensive summary of the clinical and pathological features, as well as treatment strategies, for non-small cell lung cancer patients with concurrent epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement.

Для цитирования: Hu Haoyue, Tan Songtao, Xie Meng, Guo Peng, Yu Qiang, Xiao Juan, Zhao Kangrui, Liao Qiong, Wang Yi. Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer.. Frontiers in pharmacology. 2023. DOI: 10.3389/fphar.2023.1167959.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.